Examine how to analyze a 483 or warning letter and learn 10 essential dos and don'ts when responding to the FDA, five common mistakes to avoid, why timelines for corrective action plans are vital and the importance of supporting documentation. Attend Responding to 483s and Warning Letters: Strategies for High-Stakes Communications, an FDAnews audioconference on Thursday, Oct. 30 from 1:30-3:00 p.m. EDT. Attorneys Fredrick H. Branding and Cathy L. Burgess will present best practices and lessons learned from decades of representing manufacturers. For more information and to register, go to www.fdanews. com/Responding-483s or call toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600.
展开▼
机译：检查在响应FDA时如何分析483或警告信并了解10个基本的要做与不要做的事情，应避免的五个常见错误，纠正措施计划的时间表为何至关重要以及支持文档的重要性。参加483s和警告信：高风险交流策略，FDAnews音频会议，10月30日，星期四，下午1：30-3：00美东时间。 Fredrick H. Branding律师和Cathy L. Burgess律师将介绍数十年来代表制造商的最佳实践和经验教训。有关更多信息和注册，请访问www.fdanews。 com / Responding-483s或致电免费电话（888）838-5578（在美国境内）或+1（703）538-7600。
展开▼
